Stericycle, Inc., together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services. The company's services also include medical waste disposal, pharmaceutical waste disposal, hazardous waste management, sustainability solutions for expired or unused inventory, secure information destruction of documents and e-media, and compliance services; and regulated recall and returns management communication, logistics, and data management services for expired, withdrawn, or recalled products. In addition, it offers compliance programs under the Steri-Safe, Clinical Services, First Practice Management, SeguriMed, and EnviroAssure brand names; and live voice and automated communication services, including afterhours answering, appointment scheduling, appointment reminders, secure messaging, and event registration. The company serves healthcare businesses, including hospitals, physician and dental practices, outpatient clinics, long-term care facilities, etc.; retailers and manufacturers; financial and professional service providers; governmental entities; and other businesses. Stericycle, Inc. was founded in 1989 and is based in Lake Forest, Illinois.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Sanitary services
Sub-IndustryEnvironmental & Facilities Services
SectorBusiness Services
SymbolNASDAQ:SRCL
CUSIP85891210
Phone847-367-5910
Debt
Debt-to-Equity Ratio0.87
Current Ratio0.81
Quick Ratio0.81
Price-To-Earnings
Trailing P/E Ratio14.33
Forward P/E Ratio13.94
P/E Growth1.43
Sales & Book Value
Annual Sales$3.58 billion
Price / Sales1.49
Cash Flow$7.6213 per share
Price / Cash8.16
Book Value$34.07 per share
Price / Book1.83
Profitability
EPS (Most Recent Fiscal Year)$4.34
Net Income$42.40 million
Net Margins5.03%
Return on Equity14.04%
Return on Assets5.82%
Miscellaneous
Employees645
Outstanding Shares85,890,000
Market Cap$5.28 billion
Stericycle (NASDAQ:SRCL) Frequently Asked Questions
What is Stericycle's stock symbol?
Stericycle trades on the NASDAQ under the ticker symbol "SRCL."
How were Stericycle's earnings last quarter?
Stericycle Inc (NASDAQ:SRCL) announced its quarterly earnings results on Thursday, August, 2nd. The business services provider reported $1.17 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.13 by $0.04. The business services provider had revenue of $883.30 million for the quarter, compared to analyst estimates of $896.62 million. Stericycle had a return on equity of 14.04% and a net margin of 5.03%. Stericycle's quarterly revenue was down 3.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.15 EPS. View Stericycle's Earnings History.
When is Stericycle's next earnings date?
What guidance has Stericycle issued on next quarter's earnings?
Stericycle issued an update on its FY18 earnings guidance on Thursday, August, 2nd. The company provided EPS guidance of $4.35-4.55 for the period, compared to the Thomson Reuters consensus estimate of $4.60. The company issued revenue guidance of $3.45-3.54 billion, compared to the consensus revenue estimate of $3.57 billion.
What price target have analysts set for SRCL?
7 brokerages have issued 1-year target prices for Stericycle's stock. Their predictions range from $61.00 to $85.00. On average, they expect Stericycle's stock price to reach $71.50 in the next year. This suggests a possible upside of 15.0% from the stock's current price. View Analyst Price Targets for Stericycle.
What is the consensus analysts' recommendation for Stericycle?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stericycle in the last year. There are currently 1 sell rating, 3 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Stericycle.
Who are some of Stericycle's key competitors?
Who are Stericycle's key executives?
Stericycle's management team includes the folowing people:
- Mr. Charles A. Alutto, Pres, CEO & Director (Age 52)
- Mr. Daniel V. Ginnetti, Exec. VP & CFO (Age 49)
- Mr. Joseph Arnold, Exec. VP & COO (Age 49)
- Ms. Ruth-Ellen Abdulmassih, Exec. VP of Communication & Related Services (Age 56)
- Ms. Brenda R. Frank, Exec. VP & Chief People Officer (Age 48)
Has Stericycle been receiving favorable news coverage?
Media coverage about SRCL stock has trended somewhat positive on Tuesday, Accern reports. The research group identifies positive and negative news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Stericycle earned a daily sentiment score of 0.14 on Accern's scale. They also gave news stories about the business services provider an impact score of 46.01 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days. View Recent Headlines for Stericycle.
Who are Stericycle's major shareholders?
Stericycle's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.26%), Wells Fargo & Company MN (3.91%), Baillie Gifford & Co. (2.99%), Clarkston Capital Partners LLC (2.91%), Fairpointe Capital LLC (2.31%) and FMR LLC (2.29%). Company insiders that own Stericycle stock include Charles A Alutto, Daniel Ginnetti, Jack W Schuler, John P Schetz, John Patience, Mark C Miller, Mike S Zafirovski, Robert S Murley and Thomas D Brown. View Institutional Ownership Trends for Stericycle.
Which institutional investors are selling Stericycle stock?
SRCL stock was sold by a variety of institutional investors in the last quarter, including Thompson Siegel & Walmsley LLC, Fairpointe Capital LLC, Global Thematic Partners LLC, Point72 Asset Management L.P., State of Wisconsin Investment Board, Van ECK Associates Corp, Mcdonald Capital Investors Inc. CA and KBC Group NV. Company insiders that have sold Stericycle company stock in the last year include Charles A Alutto, Daniel Ginnetti, John Patience, Mark C Miller and Thomas D Brown. View Insider Buying and Selling for Stericycle.
Which institutional investors are buying Stericycle stock?
SRCL stock was acquired by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, FMR LLC, Reinhart Partners Inc., Los Angeles Capital Management & Equity Research Inc., Diamond Hill Capital Management Inc., Renaissance Technologies LLC, Ariel Investments LLC and Millennium Management LLC. Company insiders that have bought Stericycle stock in the last two years include Jack W Schuler, Mike S Zafirovski and Robert S Murley. View Insider Buying and Selling for Stericycle.
How do I buy shares of Stericycle?
Shares of SRCL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Stericycle's stock price today?
One share of SRCL stock can currently be purchased for approximately $62.19.
How big of a company is Stericycle?
Stericycle has a market capitalization of $5.28 billion and generates $3.58 billion in revenue each year. The business services provider earns $42.40 million in net income (profit) each year or $4.34 on an earnings per share basis. Stericycle employs 645 workers across the globe.
How can I contact Stericycle?
Stericycle's mailing address is 28161 NORTH KEITH DRIVE, LAKE FOREST IL, 60045. The business services provider can be reached via phone at 847-367-5910 or via email at [email protected]
MarketBeat Community Rating for Stericycle (NASDAQ SRCL)
MarketBeat's community ratings are surveys of what our community members think about Stericycle and other stocks. Vote "Outperform" if you believe SRCL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SRCL will underperform the S&P 500 over the long term. You may vote once every thirty days.
